TY  - GEN
AU  - Felgueres, María-José
AU  - Esteso, Gloria
AU  - García-Jiménez, Álvaro F
AU  - Dopazo, Ana
AU  - Aguiló, Nacho
AU  - Mestre-Durán, Carmen
AU  - Martínez-Piñeiro, Luis
AU  - Pérez-Martínez, Antonio
AU  - Reyburn, Hugh T
AU  - Valés-Gómez, Mar
PY  - 2024
UR  - https://hdl.handle.net/20.500.12105/25900
AB  - The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological basis, detailed phenotype and function of...
LA  - eng
PB  - Nature Publishing Group
KW  - BCG
KW  - Cancer immunology
KW  - Cell immunotherapy
KW  - Cytokine activation
KW  - NK cells
TI  - BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.
TY  - research article
ER  -